Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications

Hanan Idris1, Sidney Lo1, Ibrahim M Shugman1

  • 1Cardiology Department, Liverpool Hospital and South Western Sydney Clinical School, The University of New South Wales, Sydney, NSW, Australia (H.I., S.L., I.M.S., Y.S., A.P.H., C.M., D.L., L.T., C.P.J., J.K.F.).

Abstract

Insights

The Society for Cardiovascular Angiography and Interventions (SCAI) definition of periprocedural myocardial infarction (PMI) identifies patients with higher rates of late death. Using the SCAI definition for PMI is crucial for accurate risk assessment.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Outcomes

Background:

  • Periprocedural myocardial infarction (PMI) lacks a universally consistent definition, impacting clinical interpretation.
  • Existing definitions, including the Society for Cardiovascular Angiography and Interventions (SCAI) criteria, vary in their diagnostic thresholds.

Purpose of the Study:

  • To evaluate the impact of different PMI definitions on event frequencies.
  • To determine if varying PMI definitions influence the association between PMI and late death/myocardial infarction (MI).

Main Methods:

  • Analysis of 742 patients undergoing cardiac procedures.
  • Comparison of PMI incidence using the 2007 universal definition, 2012 universal definition, and the SCAI definition.
  • Assessment of 2-year rates of death/MI based on PMI classification.

Main Results:

  • PMI incidence varied significantly by definition: 23.2% (2007), 13.3% (2012), and 2.6% (SCAI).
  • The SCAI definition identified a subset of patients with significantly higher rates of late death/MI (29.4%) compared to other definitions.
  • Side branch occlusion ≤1 mm was the most common angiographic finding in SCAI-defined PMI.

Conclusions:

  • The SCAI definition of PMI is associated with increased late death/MI rates.
  • A substantial proportion of patients meeting the 2007 universal definition did not meet the SCAI criteria, highlighting definitional discrepancies.
  • Adopting the SCAI definition may refine risk stratification for patients experiencing periprocedural myocardial infarction.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
512
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.2K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
630
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
485
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
762